BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38536615)

  • 21. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.
    Saito R; Krauze MT; Noble CO; Drummond DC; Kirpotin DB; Berger MS; Park JW; Bankiewicz KS
    Neuro Oncol; 2006 Jul; 8(3):205-14. PubMed ID: 16723630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concentration and timing dependence of lethality enhancement between topotecan, a topoisomerase I inhibitor, and ionizing radiation.
    Lamond JP; Wang M; Kinsella TJ; Boothman DA
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):361-8. PubMed ID: 8892461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.
    Yamashita Y; Krauze MT; Kawaguchi T; Noble CO; Drummond DC; Park JW; Bankiewicz KS
    Neuro Oncol; 2007 Jan; 9(1):20-8. PubMed ID: 17018695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaluronic acid-grafted polyamidoamine dendrimers enable long circulation and active tumor targeting simultaneously.
    Qi X; Fan Y; He H; Wu Z
    Carbohydr Polym; 2015 Aug; 126():231-9. PubMed ID: 25933544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal encapsulation increases the activity of the topoisomerase I inhibitor topotecan.
    Subramanian D; Muller MT
    Oncol Res; 1995; 7(9):461-9. PubMed ID: 8835290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using plasma topotecan pharmacokinetics to estimate topotecan exposure in cerebrospinal fluid of children with medulloblastoma.
    Freeman BB; Iacono LC; Panetta JC; Gajjar A; Stewart CF
    Neuro Oncol; 2006 Apr; 8(2):89-95. PubMed ID: 16461424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines.
    Zamboni WC; Houghton PJ; Hulstein JL; Kirstein M; Walsh J; Cheshire PJ; Hanna SK; Danks MK; Stewart CF
    Cancer Chemother Pharmacol; 1999; 43(4):269-76. PubMed ID: 10071976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.
    Sorensen M; Sehested M; Jensen PB
    Br J Cancer; 1995 Aug; 72(2):399-404. PubMed ID: 7640225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment with ranitidine does not reduce the bioavailability of orally administered topotecan.
    Akhtar S; Beckman RA; Mould DR; Doyle E; Fields SZ; Wright J
    Cancer Chemother Pharmacol; 2000; 46(3):204-10. PubMed ID: 11021737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development, Characterization, and Evaluation of SLN-Loaded Thermoresponsive Hydrogel System of Topotecan as Biological Macromolecule for Colorectal Delivery.
    Xing R; Mustapha O; Ali T; Rehman M; Zaidi SS; Baseer A; Batool S; Mukhtiar M; Shafique S; Malik M; Sohail S; Ali Z; Zahid F; Zeb A; Shah F; Yousaf A; Din F
    Biomed Res Int; 2021; 2021():9968602. PubMed ID: 34285920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer.
    Webb MS; Logan P; Kanter PM; St-Onge G; Gelmon K; Harasym T; Mayer LD; Bally MB
    Cancer Chemother Pharmacol; 1998; 42(6):461-70. PubMed ID: 9788572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.
    Patel KJ; Trédan O; Tannock IF
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):127-38. PubMed ID: 23680920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
    Tardi P; Choice E; Masin D; Redelmeier T; Bally M; Madden TD
    Cancer Res; 2000 Jul; 60(13):3389-93. PubMed ID: 10910044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.
    Rowinsky EK; Adjei A; Donehower RC; Gore SD; Jones RJ; Burke PJ; Cheng YC; Grochow LB; Kaufmann SH
    J Clin Oncol; 1994 Oct; 12(10):2193-203. PubMed ID: 7931489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro assessment of liposomal topotecan simulating metronomic chemotherapy in combination with radiation in tumor-endothelial spheroids.
    Jyoti A; Fugit KD; Sethi P; McGarry RC; Anderson BD; Upreti M
    Sci Rep; 2015 Oct; 5():15236. PubMed ID: 26468877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel core-shell lipid nanoparticle for improving oral administration of water soluble chemotherapeutic agents: inhibited intestinal hydrolysis and enhanced lymphatic absorption.
    Wang T; Shen L; Zhang Z; Li H; Huang R; Zhang Y; Quan D
    Drug Deliv; 2017 Nov; 24(1):1565-1573. PubMed ID: 29029577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy.
    Zucker D; Andriyanov AV; Steiner A; Raviv U; Barenholz Y
    J Control Release; 2012 Jun; 160(2):281-9. PubMed ID: 22019556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Therapeutic Efficacy of Topotecan Against A549 Lung Cancer Cells with Folate-targeted Topotecan Liposomes.
    Zhang J; Shi W; Xue G; Ma Q; Cui H; Zhang L
    Curr Drug Metab; 2020; 21(11):902-909. PubMed ID: 32851958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.